December 2, 2020
2016, 2017, 2018, 2019, 2019, 2020, API, Astrological Video, Audit and Guideline, Audit and Routine Checklist, Beauty tips, Cleaning Validation(CV), Computer System Validation, Coronavirus updates, Cosmetics and pharmaceutical, Design Qualification, Diet and Nutrition, Discount Coupon, Drug and supplements, DRUGS AND COSMETICS ACT 1940 AND RULES 1945, Education in Ukraine, email, Engineering, Factory Acceptance Test, FDA News, Featured, FINISHED PRODUCT, Fitness News, Flipkart, Health news, HR SOP, Innovator Medicines Details, Installation Qualification(IQ), Jobs, Latest News, Link For Guideline, Master Formula, Microbiology, Motivational & Social Video, Operational Qualification(OQ), Other, Other Topic, Other Topic, Other Topic, Other Topic, Other Topic, other video, Performance Qualification(PQ), Presentation, Presentation, Presentation, Presentation, Presentation, Process Validation(PV), Production, QA & QC, Qualification, Quality Assurance, Quality Assurance, Quality Control, Question Forum, Question Forum, Question Forum, Question Forum, Revalidation/requalification, Risk Assesment, Risk Assessment, Site Acceptance Test, Social Awareness, SOP, SOP, SOP, SOP, User Requirement Specification(URS), USFDA WARNING LETTER, Validation, Validation & Qualification, Warehouse, Water for Pharmaceutical use
575
All Post URL of Drugs formulations Tablets MFR of Albendazole Tablets – (drugsformulations.com) MFR of Alfacalcidol & Calcium Carbonate Tablets (drugsformulations.com) MFR of Sildenafil Citrate Tablets (drugsformulations.com) MFR of Paracetamol & Dicyclomine HCl Tablets – (drugsformulations.com) MFR of Dextromethorphan, Bromhexine, Chlorpheniramine Maleate & Guaifenesin Tablets (drugsformulations.com) Dextromethorphan (drugsformulations.com) Spiramycin Tablet (drugsformulations.com) MFR of Propranolol Hydrochloride …
Read More »
August 8, 2020
2016, 2017, 2018, 2019, 2019, 2020, API, Astrological Video, Audit and Guideline, Audit and Routine Checklist, Beauty tips, Cleaning Validation(CV), Computer System Validation, Coronavirus updates, Cosmetics and pharmaceutical, Design Qualification, Diet and Nutrition, Discount Coupon, Drug and supplements, DRUGS AND COSMETICS ACT 1940 AND RULES 1945, Education in Ukraine, email, Engineering, Factory Acceptance Test, FDA News, Featured, FINISHED PRODUCT, Fitness News, Flipkart, Health news, HR SOP, Innovator Medicines Details, Installation Qualification(IQ), Jobs, Latest News, Link For Guideline, Master Formula, Microbiology, Motivational & Social Video, Operational Qualification(OQ), Other, Other Topic, Other Topic, Other Topic, Other Topic, Other Topic, other video, Performance Qualification(PQ), Presentation, Presentation, Presentation, Presentation, Presentation, Process Validation(PV), Production, QA & QC, Qualification, Quality Assurance, Quality Assurance, Question Forum, Question Forum, Question Forum, Question Forum, Revalidation/requalification, Risk Assesment, Risk Assessment, Site Acceptance Test, Social Awareness, SOP, SOP, SOP, SOP, Uncategorized, User Requirement Specification(URS), USFDA WARNING LETTER, Validation, Validation & Qualification, Warehouse
2,494
Pharmaguidances Whats App Groups Pharmaguidances Pharma Post and Jabs Pharma Vacancy Pharma Post and Jabs 2 Pharmaguideline Pharmaguideline 2 MFR of SALBUTAMOL SULPHATE TABLET Pharmaceutical GuidanaceMr. Shiv Kumar is the Author and founder of pharmaceutical guidance, he is a pharmaceutical …
Read More »
April 14, 2020
2019, FINISHED PRODUCT, USFDA WARNING LETTER
761
Lohxa LLC MARCS-CMS 581785 — September 10, 2019 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning Letter …
Read More »
April 14, 2020
2019, FINISHED PRODUCT, USFDA WARNING LETTER
528
Teligent Pharma, Inc. MARCS-CMS 587592 — November 26, 2019 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning …
Read More »
April 14, 2020
2019, FINISHED PRODUCT, USFDA WARNING LETTER
728
OHM Pharma, Inc. MARCS-CMS 586428 — November 19, 2019 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning …
Read More »
April 14, 2020
2019, FINISHED PRODUCT, USFDA WARNING LETTER
582
Alkermes, Inc. MARCS-CMS 597260 — December 02, 2019 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning Letter …
Read More »
April 14, 2020
2019, FINISHED PRODUCT, USFDA WARNING LETTER
455
Pharmalab Enterprises, Inc. MARCS-CMS 588432 — December 10, 2019 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning …
Read More »
April 14, 2020
2019, FINISHED PRODUCT, USFDA WARNING LETTER
388
Wild Child WA Pty Ltd. MARCS-CMS 589463 — December 06, 2019 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more …
Read More »
April 14, 2020
2019, FINISHED PRODUCT, USFDA WARNING LETTER
802
Unipharma, LLC MARCS-CMS 585388 — November 06, 2019 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning Letter …
Read More »
April 14, 2020
2019, FINISHED PRODUCT, USFDA WARNING LETTER
611
LNK International, Inc. MARCS-CMS 582253 — September 26, 2019 For Warning Letter Click Here – Matters described in FDA warning letters may have been subject to subsequent interaction between FDA and the letter recipient that may have changed the regulatory status of issues discussed in the letter. For more USFDA warning …
Read More »